[{"Assets_0_Q2_USD":58805000.0,"CommonStockSharesOutstanding_0_Q2_shares":17740000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":2072000.0,"NetIncomeLoss_1_Q2_USD":-25000.0,"NetIncomeLoss_2_Q2_USD":207000.0,"StockholdersEquity_0_Q2_USD":55733000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":17711.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":18156.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":17711.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":17694.0,"Ticker":"FLGT","CIK":"1674930","name":"FULGENT GENETICS, INC.","OfficialName":"Fulgent Genetics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1793543393.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20170814"}]